About: Ivermectin and COVID-19: a report in Antiviral Research, widespread interest, an FDA warning, two letters to the editor and the authors' responses

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Ivermectin and COVID-19: a report in Antiviral Research, widespread interest, an FDA warning, two letters to the editor and the authors' responses Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Ivermectin and COVID-19: a report in Antiviral Research, widespread interest, an FDA warning, two letters to the editor and the authors' responses
Creator	David, A Jans, Kylie Wagstaff,
Source	Elsevier; Medline; PMC
abstract	covid:ee5c33eab1f1d9c2b43507d7b0770b20989a5b86#abstract
has issue date	2020-04-21(xsd:dateTime)
bibo:doi	10.1016/j.antiviral.2020.104805
bibo:pmid	32330482
has license	els-covid
sha1sum (hex)	ee5c33eab1f1d9c2b43507d7b0770b20989a5b86
schema:url	https://doi.org/10.1016/j.antiviral.2020.104805
resource representing a document's title	Ivermectin and COVID-19: a report in Antiviral Research, widespread interest, an FDA warning, two letters to the editor and the authors' responses
has PubMed Central identifier	PMC7172803
has PubMed identifier	32330482
schema:publication	Antiviral Res
resource representing a document's body	covid:ee5c33eab1f1d9c2b43507d7b0770b20989a5b86#body_text
is schema:about of	named entity 'SARS-CoV-2' named entity 'plasma' named entity 'adverse effects' named entity 'postnatal' named entity 'Mike Bray' named entity 'US FDA' named entity 'ivermectin' named entity 'supernatant' named entity 'ivermectin' named entity 'COVID-19' named entity 'Ivermectin' named entity 'SARS-CoV-2' named entity 'lung' named entity 'RT-PCR' named entity 'lung tissue' named entity 'lung tissue' named entity 'covid-19' named entity 'ivermectin' named entity 'RNA' named entity 'ivermectin' named entity 'SARS-CoV-2' named entity 'COVID-19' named entity 'ivermectin' named entity 'supernatant' named entity 'ivermectin' named entity 'onchocerciasis' named entity 'FDA' named entity 'viral RNA' named entity 'SARS-CoV-2' named entity 'Mectizan' named entity 'cell culture' named entity 'ivermectin' named entity 'administered orally' named entity 'Cmax' named entity 'macrocyclic' named entity 'viral RNA' named entity 'ivermectin' named entity 'usual doses' named entity 'Brazil' named entity 'ivermectin' named entity 'SARS-CoV-2' named entity 'COVID-19 pandemic' named entity 'meta-analysis' named entity 'plasma' named entity 'fda' named entity 'Strongyloidiasis' named entity 'PK/PD' named entity 'ivermectin' named entity 'Monash University' named entity 'micromolar' named entity 'ivermectin' named entity 'veterinary products' named entity 'Lima' named entity 'phase 1' named entity 'pharmacology' named entity 'Australia' named entity 'PBPK' named entity 'plasma' named entity 'Biochemical' named entity 'Cmax' named entity 'Antiviral Research' named entity 'virus' named entity 'plasma' named entity 'ivermectin' named entity 'viral RNA' named entity 'administered orally' named entity 'onchocerciasis' named entity 'macrocyclic lactones' named entity 'ivermectin' named entity 'neglected tropical diseases' named entity 'plasma' named entity 'Onchocerca volvulus' named entity 'SARS-CoV-2' named entity 'drug development' named entity 'pharmacokinetic' named entity 'SARS-CoV-2' named entity '5µM' named entity 'SARS-CoV-2' named entity 'carcinogenicity'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software